Guanidine-modified albumin-MMAE conjugates with enhanced endocytosis ability

References

• Alvarez B, Carballal S, Turell L, Radi R. (2010). Formation and reactions of sulfenic acid in human serum albumin. Methods Enzymol 473:1–16.
   PubMed Web of Science ®Google Scholar
• Choi SW, Sato Y, Akaike T, Maruyama A. (2004). Preparation of cationic comb-type copolymer having Guanidino Moieties and its interaction with DNAs. J Biomater Sci Polym Ed 15:1099–110.
   PubMed Web of Science ®Google Scholar
• Dumontet C, Jordan MA. (2010). Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 9:790–803.
   PubMed Web of Science ®Google Scholar
• Fiehn C, Kratz F, Sass G, et al. (2008). Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Ann Rheum Dis 67:1188–91.
   PubMed Web of Science ®Google Scholar
• Gong J, Yan J, Forscher C, Hendifar A. (2018). Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas. Drug Des Devel Ther 12:777–86.
   PubMed Web of Science ®Google Scholar
• Huang Z, Pang X, Zhong T, et al. (2022). Penpulimab, an Fc-engineered IgG1 anti-PD-1 antibody, with improved efficacy and low incidence of immune-related adverse events. Front Immunol 13:924542.
   PubMed Web of Science ®Google Scholar
• Huber CA, Pflüger V, Reed S, et al. (2019). Bacterial identification using a SCIEX. J Microbiol Methods 164:105685.
   PubMed Web of Science ®Google Scholar
• Ikeda T, Ledwith A, Bamford CH, Hann RA. (1984). Interaction of a polymeric biguanide biocide with phospholipid membranes. Biochim Biophys Acta 769:57–66.
   PubMed Web of Science ®Google Scholar
• Ixon JE, Osman G, Morris GE, et al. (2016). Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides. Proc Natl Acad Sci U S A 113:E291–E299.
   PubMed Web of Science ®Google Scholar
• Kannan A, Giddings J, Mehta S, et al. (2022). A mechanistic understanding of monoclonal antibody interfacial protection by hydrolytically degraded polysorbate 20 and 80 under IV bag conditions. Pharm Res 39:563–75.
   PubMed Web of Science ®Google Scholar
• Kratz F. (2007). DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials. Expert Opin Investig Drugs 16:855–66.
   PubMed Web of Science ®Google Scholar
• Kratz F. (2008). Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132:171–83.
   PubMed Web of Science ®Google Scholar
• Kurzawa L, Pellerano M, Morris MC. (2010). PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells. Biochim Biophys Acta 1798:2274–85.
   PubMed Web of Science ®Google Scholar
• Li FQ, Su H, Wang J, et al. (2008). Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting. Int J Pharm 349:274–82.
   PubMed Web of Science ®Google Scholar
• Liu X, Mohanty RP, Maier EY, et al. (2020). Controlled loading of albumin-drug conjugates ex vivo for enhanced drug delivery and antitumor efficacy. J Control Release 328:1–12.
   PubMed Web of Science ®Google Scholar
• Martin AL, Bernas LM, Rutt BK, et al. (2008). Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines. Bioconjug Chem 19:2375–84.
   PubMed Web of Science ®Google Scholar
• McCann TE, Kosaka N, Mitsunaga M, et al. (2010). Biodistribution and excretion of monosaccharide-albumin conjugates measured with in vivo near-infrared fluorescence imaging. Bioconjug Chem 21:1925–32.
   PubMed Web of Science ®Google Scholar
• Posey ND, Hango CR, Minter LM, Tew GN. (2018). The role of cargo binding strength in polymer-mediated intracellular protein delivery. Bioconjug Chem 29:2679–90.
   PubMed Web of Science ®Google Scholar
• Postupalenko V, Desplancq D, Orlov I, et al. (2015). Protein delivery system containing a nickel-immobilized polymer for multimerization of affinity-purified his-tagged proteins enhances cytosolic transfer. Angew Chem Int Ed Engl 54:10583–6.
   PubMed Web of Science ®Google Scholar
• Sleep D, Cameron J, Evans LR. (2013). Albumin as a versatile platform for drug half-life extension. Biochim Biophys Acta 1830:5526–34.
   PubMed Web of Science ®Google Scholar
• Tao FH. (2017). Study on the Preparation of Drug Loaded Nanoparticles with Bovine Serum Albumin Conjugated Biguanides and its Anti-Tumor Effect. Jiangsu University.
   Google Scholar
• Tao HY, Wang RQ, Sheng WJ, Zhen YS. (2021). The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy. Int J Biol Macromol 187:24–34.
   PubMed Web of Science ®Google Scholar
• Xiao D, Luo L, Li J, et al. (2021). Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation. Bioorg Chem 116:105366.
   PubMed Web of Science ®Google Scholar
• Xiao D, Zhao L, Xie F, et al. (2021). A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate. Theranostics 11:2550–63.
   PubMed Web of Science ®Google Scholar
• Yousefpour P, Ahn L, Tewksbury J, et al. (2019). Conjugate of doxorubicin to albumin-binding peptide outperforms aldoxorubicin. Small 15:e1804452.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yu P, Gou Y, et al. (2019). Novel brain-tumor-inhibiting copper(II) compound based on a human serum albumin (HSA)-cell penetrating peptide conjugate. J Med Chem 62:10630–44.
   PubMed Web of Science ®Google Scholar
• Zu Y, Zhang Y, Zhao X, et al. (2009). Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM). Int J Nanomedicine 4:321–33.
   PubMed Web of Science ®Google Scholar